Article
Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis.
EMBO molecular medicine - 1 Mar 2018
Joshi Amit U, Saw Nay L, Vogel Hannes, Cunnigham Anna D, Shamloo Mehrdad, Mochly-Rosen Daria
Abstract excerpt
Bioenergetic failure and oxidative stress are common pathological hallmarks of amyotrophic lateral sclerosis (ALS), but whether these could be targeted effectively for novel therapeutic intervention needs to be determined. One of the reported contributors to ALS pathology is mitochondrial dysfunction associated with excessive mitochondrial fission and fragmentation, which is predominantly mediated by Drp1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
